Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Pediatric Drugs Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

The market size of pediatric drugs has witnessed a swift expansion in the past years. The growth is projected to continue, as it is set to advance from $157 billion in 2024 to $179.43 billion in 2025, riding on a compound annual growth rate (CAGR) of 14.3%. Factors that contributed to this augment during the historical period include the escalating demand for pertinent drugs, a surge in the pediatric populace, heightened cognizance of pediatric ailments, enlargement of pediatric oncology, the advent of digital health and telemedicine, as well as an upsurge in collaboration concerning pediatric drug evolution._x000D_

_x000D_

The market size of pediatric drugs is anticipated to swiftly expand in the subsequent few years, projected to reach $308.57 billion in 2029 with a compound annual growth rate (CAGR) of 14.5%. The forecasted growth can be associated with a surge in the pediatric population, escalating frequency of pediatric mental health problems, an increase in the number of children suffering from chronic diseases, elevated vaccination rates among children, and growing demand for pediatric mental health medicines. The key trends observable in this forecast period comprise bespoke pediatric medicine, the incorporation of technology in pediatric drug administration, telemedicine along with digital health solutions, improved pediatric clinical trials and cooperative efforts between pediatricians and pharmacists._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Pediatric Drugs Industry?#_x000D_

The escalation in the number of premature deliveries is projected to accelerate the expansion of the pediatric drugs market. Premature births are referred to those newborns who are born prior to the 37 weeks of gestation, as opposed to the normal 40-week term. This rise in preterm births is allied to elements such as elevated maternal age, lifestyle decisions, medical complications, multiple gestations, and insufficient prenatal attention. Pediatric medicines play a crucial role in promoting the health and growth of premature babies by presenting specialized treatments for problems such as respiratory ailments, infections, and dietary deficiencies. For instance, as per a report released by Tommy’s, a charitable entity based in the UK, in December 2022, the rate of premature live births in England and Wales escalated to 7.9% in 2022 from 7.5% in 2021. This indicates that over 53,000 babies were born prematurely in 2022. Consequently, the surge in preterm births is contributing to the growth of the pediatric drugs market._x000D_

_x000D_

#How Is the Pediatric Drugs Market Segmented?#_x000D_

The pediatric drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs_x000D_

2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations_x000D_

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels_x000D_

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids _x000D_

2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs) _x000D_

3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives _x000D_

4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21249&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Pediatric Drugs Market Growth?#_x000D_

North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Pediatric Drugs Industry?#_x000D_

Leading firms in the pediatric drugs market are channeling their efforts towards the creation of novel drugs like fully human monoclonal antibodies, with the aim to enhance treatment results and lessen adverse effects in children. Fully human monoclonal antibodies are formulated entirely from human genetic sequences, thereby reducing the probability of immune system responses when contrasted with chimeric or humanized monoclonal antibodies. Advanced biotechnology methodologies such as transgenic mice with human antibody genes or phage display technology are utilized to produce these antibodies. For instance, in August 2022, Johnson and Johnson, a pharmaceutical enterprise based in the US, gained FDA approval for STELARA (ustekinumab), a medication purposed to treat pediatric patients six years and older afflicted by active psoriatic arthritis (PsA). The approval signifies a substantial progression as STELARA is the inaugural and sole biologic therapy directed at interleukin-12 (IL-12) and interleukin-23 (IL-23), primary cytokines implicated in the inflammatory processes connected with autoimmune diseases. Active PsA is a rare disorder affecting roughly 5-8% of children with chronic inflammatory arthritis, culminating in symptoms such as joint swelling and skin lesions._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report_x000D_

_x000D_

#How Is the Pediatric Drugs Market Defined and What Are Its Core Parameters?#_x000D_

Pediatric drugs are medications specifically formulated, dosed, or approved for use in infants, children, and adolescents. These drugs are designed to treat various medical conditions in pediatric patients, considering their unique physiological and metabolic differences from adults._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21249_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model